| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Nuclear receptor coactivator 3 (NCOA3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY405554 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor coactivator 1 (NCOA1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY401228 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor coactivator 4 (NCOA4), transcript variant 4 from ORIGENE TECHNOLOGIES | LY428771 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor coactivator 4 (NCOA4), transcript variant 5 from ORIGENE TECHNOLOGIES | LY401665 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor coactivator 7 (NCOA7), transcript variant 1 from ORIGENE TECHNOLOGIES | LY405613 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor coactivator 3 (NCOA3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY401958 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor coactivator 4 (NCOA4), transcript variant 3 from ORIGENE TECHNOLOGIES | LY428770 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor interacting protein 1 (NRIP1) from ORIGENE TECHNOLOGIES | LY418644 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor interacting protein 3 (NRIP3) from ORIGENE TECHNOLOGIES | LY412407 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 5, group A, member 1 (NR5A1) from ORIGENE TECHNOLOGIES | LY417628 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 4, group A, member 3 (NR4A3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY429326 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 4, group A, member 3 (NR4A3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY416280 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 4, group A, member 3 (NR4A3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY430394 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 4, group A, member 3 (NR4A3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY406643 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 6, group A, member 1 (NR6A1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY419899 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 0, group B, member 1 (NR0B1) from ORIGENE TECHNOLOGIES | LY424702 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 0, group B, member 2 (NR0B2) from ORIGENE TECHNOLOGIES | LY402893 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 5, group A, member 2 (NR5A2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY401255 | 100 ug | ORIGENE TECHNOLOGIES |
| B4GALT7 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH300258 | 10 ug | ORIGENE TECHNOLOGIES |
| B3GAT3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN403223 | 1 kit | ORIGENE TECHNOLOGIES |
| B3GAT2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN424329 | 1 kit | ORIGENE TECHNOLOGIES |
| B3GAT1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN403716 | 1 kit | ORIGENE TECHNOLOGIES |
| B3gat2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN501917 | 1 kit | ORIGENE TECHNOLOGIES |
| B3gat1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN501916 | 1 kit | ORIGENE TECHNOLOGIES |
| B4gat1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN501920 | 1 kit | ORIGENE TECHNOLOGIES |
| B3gat3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN501918 | 1 kit | ORIGENE TECHNOLOGIES |
| BGLAP - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN420555 | 1 kit | ORIGENE TECHNOLOGIES |
| Bglap - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN502150 | 1 kit | ORIGENE TECHNOLOGIES |
| B3GAT3 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH303223 | 10 ug | ORIGENE TECHNOLOGIES |
| Bglap3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN502152 | 1 kit | ORIGENE TECHNOLOGIES |
| B3GLCT - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN409884 | 1 kit | ORIGENE TECHNOLOGIES |
| BGLAP Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH320555 | 10 ug | ORIGENE TECHNOLOGIES |
| B3glct - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN501919 | 1 kit | ORIGENE TECHNOLOGIES |
| BGN - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN200715 | 1 kit | ORIGENE TECHNOLOGIES |
| BGN - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN200715BN | 1 kit | ORIGENE TECHNOLOGIES |
| BGN - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN200715LP | 1 kit | ORIGENE TECHNOLOGIES |
| Bglap2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN502151 | 1 kit | ORIGENE TECHNOLOGIES |
| BGN - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN200715RB | 1 kit | ORIGENE TECHNOLOGIES |
| BGN - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN400715 | 1 kit | ORIGENE TECHNOLOGIES |
| B3GNT5 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN206965 | 1 kit | ORIGENE TECHNOLOGIES |
| B3GNT5 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN206965BN | 1 kit | ORIGENE TECHNOLOGIES |
| B3GNT5 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN206965LP | 1 kit | ORIGENE TECHNOLOGIES |
| Bgn - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN502153 | 1 kit | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR560949 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR561480 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR561481 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR561214 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR562092 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary-Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR815058 | n/a | ORIGENE TECHNOLOGIES |
| Human RNA: Ovary-Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIES | CR566309 | n/a | ORIGENE TECHNOLOGIES |